MIRA Pharmaceuticals Inc. (MIRA): יחס שווי שוק להכנסות החברה

MIRA Pharmaceuticals synthesizes selective cannabinoid analogs for the therapy of neurological pathologies. The price/sales ratio demonstrates a market equilibrium of value to revenue, where reflects the baseline level of the metric. The company is currently attracting investment to combat neuropathic pain, while contract manufacturing plants prepare production lines for the release of pilot batches of new neuroprotectors and analgesics.

The P/S ratio serves as an investment reliability filter, preventing the purchase of overvalued assets. This metric compares a company's total market capitalization with its annual sales volume to determine the cost per unit of revenue. By analyzing the capitalization-to-revenue ratio, an investor can gauge the degree of market overheating relative to actual earnings. For MIRA Pharmaceuticals (MIRA), at the R&D stage, this indicator is supplemented by monitoring the burn rate of liquidity used for molecule synthesis.